Academic Journal

PharmaEconomics

1 Papers Indexed in Blossom

Data updated October 28, 2025

Research Footprint

PharmaEconomics has 1 tracked paper indexed in Blossom (2023) from 4 authors, most often covering Esketamine and Ketamine, across Depressive Disorders, Adolescents and Major Depressive Disorder (MDD).

Published Papers

Open Accessmeta

Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy

This economic analysis (Markov modelling) of esketamine treatment for depression (TRD) in Italy shows that it may be cost-effective from a societal perspective.

Published: January 20, 2023
Journal: PharmaEconomics
Authors: Rognoni, C., Falivena, C., Costa, F., Armeni, P.

Quick Facts

Papers Indexed: 1
Publisher: Adis International
Website: Visit

PharmaEconomics

Research Footprint

Published Papers

Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy

Quick Facts

Company

Product

Legal